Organotics, a brain organoid startup, uses AI and patient-derived brain models to fast-track personalized medicine for autism and reduce psychiatric drug failure.

A group of European venture capital firms is banding together to try to improve the funding landscape for biotech startups.

Gotham Biotech’s lease at 6 Main St. in Gray is a straight shot to the highway, an important consideration for overnight shipping of the perishable products. PHOTO / COURTESY COLLIERS OF MAINE A ...

Four drug companies — Agomab Therapeutics, Eikon Therapeutics, Spyglass Pharma, and Veradermics — went public this week, ...

A global pharmaceutical company is moving into Center City next year — and it could be a “game-changing” development for Philly’s biotech scene, a leader in the space says. “We see it as a ...

Eli Lilly will acquire Orna Therapeutics for up to $2.4 billion to gain access to the Watertown biotech's circular RNA ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A Massachusetts biotech working ...

Amelia Zellander won Startup of the Year 2025 at BioLabs Philadelphia's Investor Day (Sarah Huffman/Technical.ly) Despite the international representation at BioLabs Philadelphia’s third annual ...

Founders and investors are rethinking exits as companies stay private longer. Early acquisitions and partial sales are ...

First national call is LIVE for new biotech fund under the Centre’s RDI initiative, signalling India’s big bet on Bioeconomy ...

European biotechs continue to face a demanding investment climate characterised by investor caution. As a result, many are ...

The NATO Innovation Fund (NIF) has made its first investment in a biotechnology startup. The alliance’s VC arm announced today that it’s co-leading a $35mn Series A round for UK-based Portal Biotech ...